Amiloride: A review

by Qianhui Sun, Peter Sever
Published 2020-11-01

The VALUE trial: a commentary

by Peter Sever
Published 2004-09-01

Renal denervation: An uncertain future

by Peter Sever
Published 2020-06-01

The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?

by Peter Sever, Sebastian L Johnston
Published 2020-05-01

New Hypertension Guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society

by Peter Sever
Published 2006-06-01

A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone

by Michael A Weber, Peter Sever, Attila Juhasz, Andrew Roberts, Charlie Cao
Published 2018-09-01

Hypotension and ischaemic stroke associated with aliskiren in the ALTITUDE trial: Sensitisation of the Bezold–Jarisch reflex?

by Peter Sever
Published 2013-03-01

ASCOT a Four Horse Race

by Peter Sever
Published 2005-06-01

Introduction

by Peter Sever
Published 2002-03-01

Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographi...

by Ben Ariff, Alice Stanton, Dean Barratt, Alex Augst, Fadi Glor, Neil Poulter, Peter Sever, Yun Xu, Alun Hughes, Simon AMcG Thom
Published 2002-06-01

The SCOPE Trial

by Peter Sever
Published 2002-06-01

ACE inhibitors in hypertension: Still a shortage of evidence

by Peter Sever
Published 2000-06-01

ALLHAT: definitive answers or continuing uncertainty?

by Peter Sever
Published 2003-03-01

Resistant hypertension and renal denervation: Who’s kidding whom?

by Peter Sever
Published 2014-09-01

Will the recent hypertension trials change the guidelines?

by Peter Sever
Published 2017-06-01